Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (11)COVID-19 (7)

Type

TypeGuidance (696)Indicators (14)News (22)NICE advice (67)Quality standards (36)Research recommendations (50)

Status

StatusAwaiting development (1)In development (4)Published (800)

Last updated

Last updatedLast 3 months (19)Last 6 months (37)Last year (99)Last 3 years (312)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (4)Clinical guidelines (103)COVID-19 NHSE/I specialty guides (1)COVID-19 rapid guidelines (3)Diagnostics guidance (22)Health technology evaluations (7)Highly specialised technologies guidance (19)Interventional procedures guidance (124)Medical technologies guidance (11)Medicines practice guidelines (1)NICE guidelines (147)Public health guidelines (29)Safe staffing guidelines (2)Social care guidelines (22)Technology appraisal guidance (367)

Advice programme

Advice programmeEvidence summaries (22)Medtech innovation briefings (45)

Showing 916 to 916 of 916 results for death

Sort by

NICE recommends innovative treatment for severe blood disorder for NHS use
Caplacizumab, with plasma exchange and immunosuppression, will be used to treat acute acquired thrombotic thrombocytopenic purpura.
Result type
News
Last updated
15 January 2024

Previous page
1
…
60
61
Current page 62
Page 62 of 62

Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Knowledge resources

About NICE
Into practice
Get involved with NICE
Jobs
News
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies